Rallybio Corporation RLYB
15.75 USD +0.06 (+0.38%)
At closeNov 6, 2026, 5:29 PM EST
15.80 +0.05 +0.32%
After hours · Nov 6, 5:29 PM ET
15.51 Day range 15.85
4.33 52-week range 17.22
- YTD
- +186.89%
- 1 year
- +208.22%
Financial health
Altman Z-Score
13.78 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
A-4 / 5 overall
- DCF 3
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 3
- P/B 4
Valuation
P/E -3.5×
FY 2019 5y median -3.1× FY 2025
P/S 36.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.5×
FY 2019 5y median 0.9× FY 2025
P/FCF -1.0×
FY 2019 5y median -1.6× FY 2025
EV/EBITDA 0.0×
FY 2019 5y median -0.9× FY 2025
EV/Sales -0.3×
FY 2019 5y median 0.0× FY 2025
FCF Yield -96.5%
FY 2019 5y median -62.4% FY 2025
Profitability
Gross Margin 89.3%
FY 2019 5y median 0.0% FY 2025
Operating Margin -3270.9%
FY 2019 5y median 0.0% FY 2025
Net Margin -1046.4%
FY 2019 5y median 0.0% FY 2025
ROE -15.5%
FY 2019 5y median -39.4% FY 2025
ROIC -48.3%
FY 2019 5y median -48.3% FY 2025
ROA -14.4%
FY 2019 5y median -36.9% FY 2025
Growth (YoY)
Revenue 34.9%
FY 2019 FY 2025
Operating Income 53.6%
FY 2019 FY 2025
EPS (diluted) 85.1%
FY 2019 FY 2025
Free Cash Flow 39.5%
FY 2019 FY 2025
Financial Health
Current Ratio 14.5×
FY 2019 5y median 14.5× FY 2025
Quick Ratio 14.5×
FY 2019 5y median 14.5× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2019 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31